United States · 
Who invested in Longboard Pharmaceuticals?
Longboard Pharmaceuticals's investors include Cormorant Asset Management.
United States · Venture startup
Who invested in Longboard Pharmaceuticals
Funding summaryUpdated 26 Oct 2026
Undisclosedraised across 1 round since 2024, from 1 source
- Latest round
- VentureJan 2024
- Investors
- 1
The rounds
- Jan 2024
Founders and team
From Longboard Pharmaceuticals's own website and the SEC filings it signed: 6 on the team.
- Kevin R LindPresident and Chief Executive Officer
- Chad OrevilloExecutive Vice President, Head of Operations
- Casey LynchBoard Member
- Paul SekhriChairman of the Board
- Phillip SchneiderBoard Member
- Vincent R AurentzBoard Member
On the board, as filediChandra R LeoLaurie R Stelzer
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Longboard Pharmaceuticals
How much has Longboard Pharmaceuticals raised?
Longboard Pharmaceuticals has raised 1 round since 2024, none with a disclosed amount.
When did Longboard Pharmaceuticals last raise?
Longboard Pharmaceuticals's most recent round was a Venture in Jan 2024.
Who backed Longboard Pharmaceuticals first?
Longboard Pharmaceuticals's first round on record, in Jan 2024, was backed by Cormorant Asset Management.
What stage is Longboard Pharmaceuticals at?
Longboard Pharmaceuticals's latest named round is a Venture, in Jan 2024.
Where is Longboard Pharmaceuticals based?
Longboard Pharmaceuticals is based in the United States.
Companies like Longboard Pharmaceuticals
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.